VEGFR2/Raf dual inhibitor (YOUAI)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameVEGFR2/Raf dual inhibitor (YOUAI)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonistsRAF serine/threonine protein kinase inhibitors
TargetsVascular endothelial growth factor receptor 2RAF serine/threonine protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesYOUAI
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYOUAI
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A